Pharma Industry News Weekly Recap: January 6, 2023
// Biotech and Pharma Therapeutics Lilly, seeking better CNS gene therapies, pays $55M to join AbbVie on AAV [...]
// Biotech and Pharma Therapeutics Lilly, seeking better CNS gene therapies, pays $55M to join AbbVie on AAV [...]
// Biotech and Pharma Therapeutics Drug companies set sights on new Covid medicines to boost depleted arsenal December [...]
// Biotech and Pharma Therapeutics Pfizer snaps up rights to RSV therapy left behind in ReViral buy for $20M [...]
// Biotech and Pharma Therapeutics A San Diego startup sees covalent biologics as the next frontier in cancer [...]
// Biotech and Pharma Therapeutics AstraZeneca beefs up COPD pipeline with $400M biobuck bet on C4X program November 28, [...]
// Biotech and Pharma Therapeutics Adamis, Harpoon, Neoleukin and Tricida add to biotech layoff wave as pipeline setbacks [...]
// Biotech and Pharma Therapeutics Early data hint at benefit for Amgen’s obesity drug November 8, 2022 / [...]
// Biotech and Pharma Therapeutics J&J wins approval of new kind of multiple myeloma drug October 26, 2022 [...]
// Biotech and Pharma Therapeutics PIC Closes $35M Series A to Advance Novel Breast Cancer Therapeutic October 19, [...]
// Biotech and Pharma Therapeutics October 10, 2022 / RNA / Startup / Chronic Liver Disease -Ochre Bio [...]